中聯(lián)重科案例分析

中聯(lián)重科案例分析2025/1/151）盈利指標(biāo)長期在同行業(yè)的對應(yīng)指標(biāo)之上。2）穩(wěn)定的股利政策。ListingorNot?

GROUP3rd——TheanalysisontheprosandconsofacompanylistingbasedonYunnan-BaiyaoCo.,Ltd.2025/1/15contents1243

ThedisadvantagesoflistedcompanyThebenefitsoflistedcompanyBriefintroductionofthecompanyConclusion2025/1/15Yunnan-BaiyaoCo.,Ltd.2025/1/15云南白藥大事記From1971to20142025/1/15

1971云南白藥廠

1993年云南白藥實業(yè)有限公司。深圳證券交易所上市，股票發(fā)行價為3.38元/股。1996年云南白藥股份有限公司。實現(xiàn)云南白藥獨家生產(chǎn)經(jīng)營

2008年產(chǎn)品收入額突破10億，股票市值達到27.87元/股。2014年總資產(chǎn)138.28億元，營業(yè)收入86.27億元。FinancingForthemanagersandemployeesForthecooperaters2025/1/15BENEFITS2025/1/15Financing1.ThebriefintroductionoftheIPO.2.Goingpublicproviderefinancingsources.3.Goingpublicisbetterfortherealizationofthedevelopmentstrategies.4.Goingpublicbringstheimprovementofthecorporateimage5.Goingpublicisgoodforimprovingtheinvestors’confidence19932000萬400萬6700萬3.38元/股時間資金來源實際募集資金（人民幣元）發(fā)行費用（人民幣元）貨幣募集資金（人民幣元）1996-01-13配股19480000742168202221682000-01-17配股71103799.76235871073462509.762008-12-30增發(fā)13639840002951600013935000002025/1/15Forthemanagersandemployees1.LessrestrictionandHigherflexibility.2.Improvetheattractionofthecorporateandthemotivationoftheemployees.3.Improvethequalityandenrichthekindsoftheproducts.4.Strengthentheloyaltyoftheemployersandthestockholders,cutdowntheprobabilityofthememberchanges.2025/1/15Forthecooperaters1.Enlargewealth.2.Easierforthestockholderstogettheirmoneyback.指標(biāo)1993199219911993每股凈資產(chǎn)2.051.121.1730%每股收益0.23?0.20?0.14?15%每股紅利0.08

股東權(quán)益比率93?5655????66股東權(quán)益1642263511032596368%Thebadinfluencesthepublicexposuremakes.Excessiveattentiontotheshort-termperformances.Highcostforgoingpublic.2025/1/15DISADVANTAGESTheintensificationtothecontradictionoftheseniorexecutiveteam.2025/1/15Thebadinfluencesthepublicexposuremakes.1.Incompleteexposurecausessocialdisturbance.2.Thebadinfluencethepublicexposuremakesforthemarketoperatingofthecorporate.3.Conclusion2025/1/15Excessiveattentiontotheshort-termperformances.2025/1/15Highcostforgoingpublic.財務(wù)顧問費用輔導(dǎo)費用承銷費用審計及驗資費用律師費用評估費用路演費用保薦費用上市初費/年費股票登記費信息披露費2025/1/15Theintensificationtothecontradictionoftheseniorexecutiveteam.1.Theinsufficientsharesbelongtoth